# Preventive Dendritic Cell Vaccination for Lynch Syndrome

> **NCT07412197** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 13 (estimated)

## Conditions studied

- Lynch Syndrome

## Interventions

- **BIOLOGICAL:** DC vaccination

## Key facts

- **NCT ID:** NCT07412197
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-12
- **Final completion:** 2036-06
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412197, "Preventive Dendritic Cell Vaccination for Lynch Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07412197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*